Bengaluru: Eliminating AIDS is a Sisyphian challenge. Treatments mostly miss the Human Immunodeficiency Virus (HIV) that are hidden in the body. But in a...
In 'Beyond Biryani', journalist Dinesh C Sharma unpacks the city's identity beyond its clichés and stereotypes, highlighting its contributions to industrial & scientific breakthroughs.
Granting patents to US firm Gilead Sciences for lenacapavir could hinder global efforts to end AIDS & restrict access to affordable generics in India, warn civil society organisations.
With children as young as nine being treated for addiction, and with crime statistics and HIV and AIDS cases climbing dramatically, police have called for a state of emergency.
Lenacapavir, developed by Gilead Sciences, was tested as a pre-exposure prophylaxis in African women & is now being tested in other groups who are among the most vulnerable to HIV.
Findings published in journal Science Advances. The scientists have also developed a protein molecule that can reduce the multiplication of the HIV virus.
Overturning NCDRC ruling, bench says 'no amount of compensation & monetary terms can undo harm caused by services' behaviour which has shaken foundation of appellant’s dignity'.
US study published in Proceedings of the National Academy of Sciences. Therapy administered to mice engrafted with human T cells resulted in suppression of virus & elimination of HIV-1.
New Delhi: During Operation Sindoor, the United States which had received intelligence suggesting that India had launched BrahMos cruise missiles to strike targets inside...
COMMENTS